You are here NBIRR Guide Approved Uses
Monday, September 25, 2017

Approved Uses

HBOT as used by the team is currently in use for 13 FDA-cleared indications (which means the manufacturer or practitioner can advertize those indications) by hundreds of physicians at nearly 1,000 locations across the nation, delivering approximately 10,000 treatments per day. The thirteen accepted indications for HBOT treatment include:

1. Air or gas embolism.
2. CO poisoning, CO poisoning complicated by cyanide poisoning (Neurological)
3. Clostridial myositis and myonecrosis (gas gangrene)
4. Crush injury, compartment syndrome, and other acute traumatic ischemias
5. Decompression sickness (Neurological)
6. Enhancement of healing in selected problem wounds (includes Diabetic Foot Wounds)
7. Exceptional blood loss anemia
8. Intracranial abscess (Neurological)
9. Necrotizing soft tissue infections
10. Osteomyelitis (refractory)
11. Radiation tissue damage (soft tissue and bony necrosis)
12. Skin grafts and flaps (compromised)
13. Thermal burns[1]

[1]Hyperbaric Oxygen Therapy: 1999 Committee Report. Editor, N.B. Hampson. Undersea and Hyperbaric Medical Society, Kensington, MD. See also: Harch PG. Application of HBOT to acute neurological conditions. Hyperbaric Medicine 1999, The 7th Annual Advanced Symposium.The Adams Mark Hotel, Columbia, South Carolina, April 9-10, 1999; and Mitton C, Hailey

 

The following conditions may or may not be covered by insurance or Medicare for the use of HBOT.

  • Autism
  • Cerebral Palsy
  • Lyme Disease
  • Migraine
  • Multiple Sclerosis
  • Near Drowning
  • Recovery from Plastic Surgery
  • Sports Injuries
  • Stroke
  • Traumatic Brain Injury
  • PTSD
Copyright 2009 by NBIRR Clinical Trial - Fundraiser Privacy StatementTerms Of Use Xhtml 1.0 CSS 2.0